Viw Magazine

The Times


.

AIM Vaccine’s 13-valent pneumonia conjugate vaccine obtained Production license

  • Written by Viw Magazine

Application for drug marketing registration duly submitted Super heavyweight items are expected to drive performance soaring

HONG KONG SAR - Media OutReach Newswire – 1 November 2024 - AIM Vaccine (06660.HK) announced on 1st November that the application for drug marketing registration of the Company's independently developed 13-valent pneumonia conjugate vaccine has been submitted to the National Medical Products Administration.

Read more

LifeStyle

Human Hair Wigs: A Practical And Natural-Looking Hair Solution

Hair plays an important role in personal style, confidence, and self-expression. Whether experienc...

The SNUGGLES Cove: Premium 2-in-1 Hooded Pet Beds for Ultimate Comfort

Finding the right pet bedding can make a real difference to your pet’s comfort and daily routine. ...

Why Hurstville Tutoring Can Support Stronger Academic Performance

Education continues becoming more demanding as students manage complex curriculums, assessment pre...

Gold Coast Party Boats: The New Luxury Must-Have

In times of global uncertainty, overcrowded tourist areas, and unpredictable weather, Gen Z and yo...

hacklink hack forum hacklink film izle hacklink สล็อตเว็บตรงholiganbetonline casinos australiasahabetonline casino australiamatbethttps://toomanyblogs.co.uk/parmabetgrandpashabet hangi ülkeningrandpashabet giriş xgrandpashabet giriş xStreameasthuqqabetThe Pokies Netmaxwin girişjojobetdizipalMeritkingdeneme bonusukulisbetjudi bolaturkbet girisVenüsbetcasibomholiganbetjojobetjojobetjojobet